Shift4 Payments FOUR Rallies 295 as Bulls Target 4431 20260520 Sharps STSSW Stock Down 180 Support Test at 004 20260520 Failed SimbaM1 Deal May Disrupt Keppels Telecom Ambitions Intensify Cost Pressures Greeces Primary Budget Surplus More Than Doubles Forecast in Early 2026 Esperion Therapeutics ESPR Unchanged at 313 RangeBound Trading 20260520 Silexion Therapeutics SLXN Gained 5613 Can It Break 044 20260520